A COMPARATIVE CLINICAL STUDY OF MEDOHARA ARKA AND MEDOHARA ARKA ALONG WITH LEKHANA VASTI ON MEDOVRIDDHI W.S.R. TO HYPERLIPIDAEMIA
DOI:
https://doi.org/10.70066/jahm.v2i9.223Keywords:
Medovriddhi, Hyperlipidaemia, Medohara Arka, Lekhana VastiAbstract
Background: Medovriddhi (hyperlipidaemia) is an alarming health problem of modern society. It is important but
modifiable risk factors in atherosclerosis, one of the major causes of hospitalization, death and loss of effective years in
middle aged and older adults that affects the cerebro vascular, cardio vascular and peripheral vascular systems.
Objectives: 1. To evaluate the effect of Medohara Arka on hyperlipidemia. 2. To evaluate the effect of medohara Arka
administered after Lekhanavasti. 3. To compare the effect of both. Method: In the present clinical study two groups were
made. In group – I, 40 patients with Hyperlipidaemia (especially raised values of either Cholesterol or Triglycerides)
availing the selection criteria were selected. In this group, Medohara Arka (prepared by distillation of cow’s urine only)
40ml. with 10ml. honey has been administered for 30 days. In group- II, 40 patients were selected who were fit for
shodhana. In this group Lekhanavasti was administered with oral administration of medohara Arka 40ml. along with
honey 10ml for 30 days. Results: After completion of 30 days treatment with trial drug – I, the average improvement with
respect to different sign and symptoms viz. - weight, BMI, skin fold thickness, total serum cholesterol, LDL cholesterol,
HDL cholesterol and Serum triglycerides were 26.6%, 26.6%, 20%, 22.12%, 8.33%, 4.17% and 0% respectively. Whereas in
group II cases the average improvements were 88.3%, 65%, 63.33%, 29.41%, 14.03%, 35.55% and 15.55% respectively.
Conclusion: The clinical assessment of result reveals that after 30 days of treatment 50% of the patients got mild
improvement but rest 50% could not get any satisfactory improvement with trial drug-I where as in Group – II, 5%
patients got maximum improvement, 75% moderate improvement, 15 % mild improvement and another 5% patients
could not get satisfactory improvement.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Nagendra Prasad

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.